159 related articles for article (PubMed ID: 27352567)
1. Ovarian yolk sac tumor in postmenopausal females: a report of five cases and a literature review.
Wang X; He J; Li Y
Eur J Gynaecol Oncol; 2016; 37(3):374-9. PubMed ID: 27352567
[TBL] [Abstract][Full Text] [Related]
2. Ovarian yolk sac tumor in postmenopausal females: A case series and a literature review.
Wang Y; Yang J; Yu M; Cao D; Zhang Y; Zong X; Shen K
Medicine (Baltimore); 2018 Aug; 97(33):e11838. PubMed ID: 30113473
[TBL] [Abstract][Full Text] [Related]
3. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.
Moran CA; Suster S; Koss MN
Cancer; 1997 Aug; 80(4):699-707. PubMed ID: 9264353
[TBL] [Abstract][Full Text] [Related]
4. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.
Satoh T; Aoki Y; Kasamatsu T; Ochiai K; Takano M; Watanabe Y; Kikkawa F; Takeshima N; Hatae M; Yokota H; Saito T; Yaegashi N; Kobayashi H; Baba T; Kodama S; Saito T; Sakuragi N; Sumi T; Kamura T; Yoshikawa H
Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616
[TBL] [Abstract][Full Text] [Related]
5. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component.
Abe A; Furumoto H; Yoshida K; Nishimura M; Irahara M; Kudo E; Sano T
Int J Gynecol Cancer; 2008; 18(1):168-72. PubMed ID: 17466041
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Yolk Sac Tumors; Does Age Matter?
Faure Conter C; Xia C; Gershenson D; Hurteau J; Covens A; Pashankar F; Krailo M; Billmire D; Patte C; Fresneau B; Shaikh F; Stoneham S; Nicholson J; Murray M; Frazier AL
Int J Gynecol Cancer; 2018 Jan; 28(1):77-84. PubMed ID: 29194189
[TBL] [Abstract][Full Text] [Related]
7. Ovarian yolk sac tumour in a girl - case report.
Sharma C; Shah H; Sisodiya Shenoy N; Makhija D; Waghmare M
Dev Period Med; 2017; 21(2):101-103. PubMed ID: 28796980
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and oncological outcomes of ovarian yolk sac tumors: a retrospective multicentric analysis of 99 cases.
Boyraz G; Durmus Y; Cicin I; Kuru O; Bostanci E; Comert GK; Sahin H; Ayik H; Ureyen I; Karalok A; Meydanli MM; Salman MC; Ozgul N; Onan A; Simsek T; Yuce K; Turan T
Arch Gynecol Obstet; 2019 Jul; 300(1):175-182. PubMed ID: 30982145
[TBL] [Abstract][Full Text] [Related]
9. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
[TBL] [Abstract][Full Text] [Related]
10. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases.
Nogales FF; Bergeron C; Carvia RE; Alvaro T; Fulwood HR
Am J Surg Pathol; 1996 Sep; 20(9):1056-66. PubMed ID: 8764742
[TBL] [Abstract][Full Text] [Related]
11. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
12. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.
de La Motte Rouge T; Pautier P; Duvillard P; Rey A; Morice P; Haie-Meder C; Kerbrat P; Culine S; Troalen F; Lhommé C
Ann Oncol; 2008 Aug; 19(8):1435-1441. PubMed ID: 18408223
[TBL] [Abstract][Full Text] [Related]
13. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
14. Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis.
Hou JY; Liu HC; Yeh TC; Sheu JC; Chen KH; Chang CY; Liang DC
Pediatr Neonatol; 2015 Oct; 56(5):301-6. PubMed ID: 25769700
[TBL] [Abstract][Full Text] [Related]
15. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors.
Rougemont AL; Tille JC
Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846
[TBL] [Abstract][Full Text] [Related]
16. Bilateral ovarian mixed epithelial adenocarcinoma in a postmenopausal woman with unilateral ovarian yolk sac tumor component.
Chen Q; Chen X
Int J Clin Exp Pathol; 2014; 7(11):8259-65. PubMed ID: 25550883
[TBL] [Abstract][Full Text] [Related]
17. Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature Review.
Boussios S; Attygalle A; Hazell S; Moschetta M; McLachlan J; Okines A; Banerjee S
Anticancer Res; 2015 Dec; 35(12):6713-22. PubMed ID: 26637887
[TBL] [Abstract][Full Text] [Related]
18. Ovarian endometrioid carcinoma with yolk sac tumor component in a postmenopausal woman.
Kabukcuoglu S; Arik D
Eur J Gynaecol Oncol; 2016; 37(6):867-869. PubMed ID: 29943939
[TBL] [Abstract][Full Text] [Related]
19. Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component.
Roth LM; Talerman A; Levy T; Sukmanov O; Czernobilsky B
Int J Gynecol Pathol; 2011 Sep; 30(5):442-51. PubMed ID: 21804392
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome and prognostic factors for yolk sac tumor of the ovary.
Umezu T; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
Nagoya J Med Sci; 2008 Mar; 70(1-2):29-34. PubMed ID: 18807293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
